News
Nestlé India And Dr. Reddy's To Form Joint Venture To Take Health Science Nutraceutical Portfolio To Consumers Across India And Other Agreed Territories
25 Apr 24
News, Contracts
Dr. Reddy's Launches Drug-Free Migraine Management Device Nerivio In Europe Following Successful Launch In India
10 Apr 24
Government, News, Regulations
Dr. Reddy's Laboratories Ltd. And Bayer Entered Into A Partnership To Market And Distribute A Second Brand Of Vericiguat In India. Under The Terms Of This Agreement, Bayer Has Granted Non-Exclusive Rights To Dr. Reddy's Under The Brand Name Gantra
5 Apr 24
News, Contracts, Global
Global Access to Weight-Loss Treatments: Indian Pharma Giants Eye Affordable Wegovy Alternatives Amid Rising Demand
22 Feb 24
Biotech, Large Cap, News, Health Care, General
Dr Reddy's Laboratories: Q3 Earnings Insights
30 Jan 24
Earnings
Dr Reddy's Laboratories Q3 EPS $0.99 Beats $0.79 Estimate, Sales $866.64M Beat $825.86M Estimate
30 Jan 24
Earnings, News
Barclays Maintains Overweight on Dr Reddy's Laboratories, Raises Price Target to $80
29 Jan 24
News, Price Target, Analyst Ratings
Press releases
Pharmazz Inc. and Dr. Reddy's Laboratories have entered into a licensing agreement to market Centhaquine (Lyfaquin) as a resuscitative agent for hypovolemic shock in India
22 Mar 24
Health Care, Press Releases
Dr. Reddy's Laboratories launches Versavo® (bevacizumab) in the UK
19 Mar 24
Press Releases
Dr. Reddy's Q3 & 9M FY24 Financial Results
31 Jan 24
Press Releases